AIM
AMAG

Arcadia Investment Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Arcadia Investment Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-780
Closed -$18K – 446
2017
Q1 		$18K Buy
+780
New +$18.7K 0.01% 338
2016
Q3 		– Sell
-825
Closed -$20K – 456
2016
Q2 		$20K Buy
+825
New +$18.9K 0.01% 338

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Arcadia Investment Management's AMAG Position: Q2 2017 in Review

Arcadia Investment Management sold out of AMAG Pharmaceuticals (AMAG) in Q2 2017, closing a stake of 780 shares — an estimated $18K sold.

Arcadia Investment Management first reported a position in AMAG in Q2 2016 and held it in 2 quarters. The position peaked at $20K in Q2 2016. 174 funds tracked by Wall St. Rank hold AMAG as of Q2 2017.

  • Arcadia Investment Management reported no remaining AMAG Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Arcadia Investment Management sold 780 AMAG Pharmaceuticals shares in Q2 2017, an estimated $18K.
  • Arcadia Investment Management first reported a position in AMAG Pharmaceuticals in Q2 2016 and held it in 2 quarters.
  • Arcadia Investment Management's AMAG Pharmaceuticals position peaked at $20K in Q2 2016.
  • 174 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2017.

Based on Arcadia Investment Management's 13F filing for Q2 2017, filed 3 Aug 2017.